thiazoles has been researched along with Hepatic Encephalopathy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Fujita, M; Hayashi, M; Hikichi, T; Imaizumi, H; Nakamura, J; Ohira, H; Sugaya, T; Takagi, T; Takahashi, A | 1 |
| Abd-Elsalam, SM; Glal, KAM; Mostafa, TM | 1 |
| Abd-Elsalam, S; Badawi, R; El-Kalla, F; Elfert, A; Elkhalawany, W; ElSawaf, MA; Elwan, N; Hawash, N; Soliman, S | 1 |
| Bernauer, E; Finsterer, J | 1 |
| Fujita, Y; Kuwao, S; Saigenji, K; Shibuya, A; Takahashi, H; Takeuchi, H; Watanabe, M | 1 |
| Booth, AM; Caldwell, SH; Iezzoni, JC | 1 |
| Albrecht, J; Borkowska, HD; Hilgier, W; Oja, SS; Saransaari, P; Zielińska, M | 1 |
2 trial(s) available for thiazoles and Hepatic Encephalopathy
| Article | Year |
|---|---|
Nitazoxanide versus rifaximin in preventing the recurrence of hepatic encephalopathy: A randomized double-blind controlled trial.
Topics: Child; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Nitro Compounds; Prospective Studies; Quality of Life; Rifamycins; Rifaximin; Thiazoles | 2021 |
A Randomized Controlled Trial Comparing Nitazoxanide Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy.
Topics: Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Nitro Compounds; Thiazoles; Treatment Outcome | 2019 |
5 other study(ies) available for thiazoles and Hepatic Encephalopathy
| Article | Year |
|---|---|
Sigmoid Colon Varices due to Massive Thrombosis of a Noncirrhotic Extrahepatic Portosystemic Shunt.
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Colon, Sigmoid; Dermatan Sulfate; Factor Xa Inhibitors; Heparitin Sulfate; Hepatic Encephalopathy; Humans; Male; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic; Pyridines; Thiazoles; Thrombosis; Treatment Outcome; Varicose Veins | 2020 |
Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy.
Topics: Anti-Bacterial Agents; Antiparkinson Agents; Benzothiazoles; Brain; Chronic Disease; Dipeptides; Evoked Potentials, Visual; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Paromomycin; Pramipexole; Recovery of Function; Thiazoles; Treatment Outcome; Vision Disorders | 2005 |
An autopsy case of troglitazone-induced fulminant hepatitis.
Topics: Alanine Transaminase; Autopsy; Bilirubin; Chromans; Diabetes Mellitus, Type 2; Fatal Outcome; Hepatic Encephalopathy; Humans; Hypoglycemic Agents; Liver; Male; Middle Aged; Prothrombin Time; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone | 1998 |
Troglitazone-associated hepatic failure.
Topics: Aged; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Fatal Outcome; Female; Hepatic Encephalopathy; Humans; Hyperlipidemias; Hypoglycemic Agents; Liver; Liver Failure; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Lubeluzole attenuates K(+)-evoked extracellular accumulation of taurine in the striatum of healthy rats and rats with hepatic failure.
Topics: Animals; Extracellular Space; Glutamic Acid; Hepatic Encephalopathy; Male; Microdialysis; Neostriatum; Neurons; Neuroprotective Agents; Osmotic Pressure; Piperidines; Potassium Chloride; Rats; Rats, Wistar; Taurine; Thiazoles; Thioacetamide | 2001 |